Carboxymethylcellulose-sodium based transdermal drug delivery system for propranolol

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 4, 1996, Pages 367-370

  Krishna, Rajesh ^a,b   Pandit, J K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBOXYMETHYLCELLULOSE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT; RAT; SKIN IRRITATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0029993170     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05934.x     Document Type: Article

References (12)

1. Ademola, J. I., Chow, C. A., Wester, R. C., Maibach, H. I. (1993) Metabolism of propranolol during percutaneous absorption in human skin. J. Pharm. Sci. 82: 767-770
2. Cargill, R., Engle, K., Rork, G., Caldwell, L. J. (1986) Systemic delivery of timolol after dermal application: transdermal flux and skin irritation potential in the rat and dog. Pharm. Res. 34: 224-229
3. Corbo, M., Liu, J. C., Chien, Y. W. (1990) Bioavailability of propranolol following oral and transdermal administration in rabbits. J. Pharm. Sci. 79: 584-587
4. de Mey, C., Enterling, D., Ederhof, M., Wesche, H., Osterwald, H. (1989a) Transdermal delivery of mepindolol and propranolol in normal man. I Study design, clinical and pharmacodynamic aspects. Arzneim Forsch. 39: 1505-1508
5. de Mey, C., Meineke, I., Enterling, D., Rehbock, C., Osterwald, H. (1989b) Transdermal delivery of mepindolol and propranolol in normal man. II Pharmacokinetic and neuro-endocrine aspects. Arzneim Forsch. 39: 1508-1512
6. Ghosh, T. K., Adir, J., Xiang, S. L., Onyilofur, S. (1995) Transdermal delivery of metoprolol II. In-vitro skin permeation and bioavailability in hairless rats. J. Pharm. Sci. 84: 158-160
7. Krishna, R., Pandit, J. K. (1993) Comparative bioavailability of propranolol following oral, intravenous, and transdermal administration in rabbits. Biopharm. Drug Dispos. 14: 785-788
8. Krishna, R., Pandit, J. K. (1994) Transdermal delivery of propranolol. Drug Dev. Ind. Pharm. 20: 2459-2465
9. O'Neill, C. T., Deasy, P. B. (1988) Development and evaluation using hairless mouse skin of a transdermal timolol product. Int. J. Pharm. 48: 247-254
10. Riddell, J. G., Haron, D. W. G., Shanks, R. G. (1987) Clinical pharmacokinetics of β-adrenoceptor antagonists. An update. Clin. Pharmacokin. 12: 305-320
11. Shand, D. G., Nuckolls, E. M., Dates, J. A. (1970) Plasma propranolol levels in adults with observations in four children. Clin. Pharmacol. Ther. 11: 112-120
12. Vlasses, P. H., Ribero, L. G. T., Rotmensch, H. H., Bondi, J. V., Loper, A. E., Hichens, M., Dunlay, M. C., Ferguson, R. K. (1985) Initial evaluation of transdermal timolol: serum concentrations and β-blockade. J. Cardiovasc. Pharmacol. 7: 245-250